Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
J Med Internet Res. 2022 Jun 14;24(6):e36787. doi: 10.2196/36787.
The C-Score, which is an individual health score, is based on a predictive model validated in the UK and US populations. It was designed to serve as an individualized point-in-time health assessment tool that could be integrated into clinical counseling or consumer-facing digital health tools to encourage lifestyle modifications that reduce the risk of premature death.
Our study aimed to conduct an external validation of the C-Score in the US population and expand the original score to improve its predictive capabilities in the US population. The C-Score is intended for mobile health apps on wearable devices.
We conducted a literature review to identify relevant variables that were missing in the original C-Score. Subsequently, we used data from the 2005 to 2014 US National Health and Nutrition Examination Survey (NHANES; N=21,015) to test the capacity of the model to predict all-cause mortality. We used NHANES III data from 1988 to 1994 (N=1440) to conduct an external validation of the test. Only participants with complete data were included in this study. Discrimination and calibration tests were conducted to assess the operational characteristics of the adapted C-Score from receiver operating curves and a design-based goodness-of-fit test.
Higher C-Scores were associated with reduced odds of all-cause mortality (odds ratio 0.96, P<.001). We found a good fit of the C-Score for all-cause mortality with an area under the curve (AUC) of 0.72. Among participants aged between 40 and 69 years, C-Score models had a good fit for all-cause mortality and an AUC >0.72. A sensitivity analysis using NHANES III data (1988-1994) was performed, yielding similar results. The inclusion of sociodemographic and clinical variables in the basic C-Score increased the AUCs from 0.72 (95% CI 0.71-0.73) to 0.87 (95% CI 0.85-0.88).
Our study shows that this digital biomarker, the C-Score, has good capabilities to predict all-cause mortality in the general US population. An expanded health score can predict 87% of the mortality in the US population. This model can be used as an instrument to assess individual mortality risk and as a counseling tool to motivate behavior changes and lifestyle modifications.
C 评分是一种个体健康评分,基于在英国和美国人群中验证的预测模型。它旨在作为一种个体化的即时健康评估工具,可以集成到临床咨询或面向消费者的数字健康工具中,以鼓励改变生活方式,降低过早死亡的风险。
本研究旨在对美国人群进行 C 评分的外部验证,并扩展原始评分以提高其在美国人群中的预测能力。C 评分适用于可穿戴设备上的移动健康应用程序。
我们进行了文献回顾,以确定原始 C 评分中缺失的相关变量。随后,我们使用 2005 年至 2014 年美国国家健康和营养检查调查(NHANES;N=21015)的数据来测试该模型预测全因死亡率的能力。我们使用 1988 年至 1994 年的 NHANES III 数据(N=1440)对该测试进行外部验证。仅纳入具有完整数据的参与者进行本研究。我们通过接收者操作曲线和基于设计的拟合优度检验,进行了区分度和校准检验,以评估经修正的 C 评分的操作特征。
更高的 C 评分与降低全因死亡率的几率相关(比值比 0.96,P<.001)。我们发现 C 评分对全因死亡率的拟合度较好,曲线下面积(AUC)为 0.72。在 40 岁至 69 岁的参与者中,C 评分模型对全因死亡率的拟合度较好,AUC>0.72。我们对 NHANES III 数据(1988-1994 年)进行了敏感性分析,结果相似。在基本 C 评分中纳入社会人口统计学和临床变量,可使 AUC 从 0.72(95%CI 0.71-0.73)增加至 0.87(95%CI 0.85-0.88)。
本研究表明,这种数字生物标志物 C 评分具有良好的预测美国一般人群全因死亡率的能力。扩展后的健康评分可预测美国人群 87%的死亡率。该模型可用于评估个体的死亡风险,并作为激励行为改变和生活方式改变的咨询工具。